Pluri (NASDAQ:PLUR – Get Rating) and Vir Biotechnology (NASDAQ:VIR – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Profitability This table compares Pluri and Vir Biotechnology’s net margins, return […]